A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer
Research output: Contribution to journal › Article › peer-review
27Scopus
citations
Fingerprint
Dive into the research topics of 'A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer'. Together they form a unique fingerprint.